General Catalyst

General Catalyst is a venture capital firm established in 2000, headquartered in Cambridge, Massachusetts, with additional offices in North America and Europe. The company specializes in early-stage and growth equity investments, focusing on technology-driven businesses. It invests across various sectors, including consumer internet, enterprise software, fintech, health assurance, and crypto. General Catalyst provides not only capital but also mentorship and resources to accelerate the growth of its portfolio companies. To date, it has managed eight venture capital funds, totaling approximately $3.75 billion in capital commitments.

Adrian Abeijon

Investor

Mark Allen

CFO

Neeraj Arora

Managing Director, Investment Team

Juliet Bailin

Principal

Marc Bhargava

Managing Director

Chris Bischoff

Managing Director

Larry Bohn

Managing Director

Teresa Carlson

President, General Catalyst Institute

Kenneth Chenault

Chairman and Managing Director

Quentin Clark

Managing Director

Mark Crane

Partner

Christopher Davis

Partner

Kyle Doherty

Managing Director

Nick van Eck

Partner

David Fialkow

Co-Founder and Managing Director

Mina Hsiang

Associate

Nmachi Jidenma

Partner

Christopher Kauffman

Principal

Genevieve Kinney

Principal

Zak Kukoff

Principal

Paul Kwan

Managing Director

Viet Le

Partner

Roy Mabrey

Partner, Investment Team

Holly Maloney McConnell

Managing Director

Karanveer Mohan

Managing Director, Investment Team

Deep Nishar

Managing Director and Member of the Management Committee

Dipchand Nishar

Managing Director

Reva Nohria

Investor

Trevor Oelschig

Managing Director

Tyler Olkowski

Investor

Pranay Orugunta

Healthcare Investor

Mo Punjwani

Associate, Investments

Candace Richardson

Principal

Paul Sagan

Investor

Pranav Singhvi

Partner

Bill Skarinka

Associate

Alex Tran

Managing Director

Catherine Tu

Partner, Investment Team

Elena Viboch

Partner

Andrea Wang

Principal, Early Stage Investment

Nathaniel Levy-Westhead

Partner, Investment Team

Past deals in Health Diagnostics

Stance Health

Pre Seed Round in 2025
Stance Health is a health technology company specializing in musculoskeletal (MSK) care. It develops a health and wellness platform that integrates medical science and technology to deliver evidence-based orthopedic rehabilitation. The company focuses on performance recovery and prevention, offering personalized programs for individuals with MSK conditions. Services include advanced diagnostic tools, tailored rehabilitation plans, and ongoing assessments, helping patients recover, prevent injuries, and improve their overall physical well-being.

Sohar Health

Seed Round in 2025
Sohar Health is a platform focused on enhancing the operations of behavioral health companies through a cloud-based eligibility verification and utilization reporting system. It provides an API-driven solution that facilitates eligibility verification and employs AI-powered medical coding to streamline manual workflows. The platform includes features designed to automate processes, manage eligibility files securely, and offer utilization analytics and reporting. This comprehensive approach enables digital health providers to scale their operations efficiently and increase revenue.

Fay

Series B in 2025
Fay is a company that connects individuals with dietitians covered by their health insurance, promoting improved dietary habits and overall well-being. It offers consulting services focused on medical nutrition therapy, enabling clients to select a dietitian and arrange either virtual or in-person consultations. Fay designs personalized nutrition plans tailored to each client's needs and works with insurance providers to ensure that these services are accessible and affordable. By facilitating customized nutrition counseling, Fay aims to enhance food-related health outcomes for its clients.

Neko Health

Series B in 2025
Neko Health is a Swedish health-tech company focused on enhancing healthcare through prevention and early detection of diseases. It has developed innovative medical scanning technology that enables comprehensive and non-invasive health data collection, making it accessible and affordable for the general public. By leveraging sensor technology and artificial intelligence, Neko Health aims to reduce the prevalence of common diseases and their associated healthcare costs. The company provides doctors and clinicians with tools for flexible and cost-effective examinations, ultimately aiming to improve the quality of healthcare and promote proactive health management.

Hippocratic AI

Series B in 2025
Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.

Orange Health Labs

Venture Round in 2024
Orange Health Labs is a health tech startup focused on providing diagnostic laboratory services that facilitate remote healthcare delivery. By enabling doctors to conduct tests and diagnostics from a patient's home, the company aims to enhance the accessibility and efficiency of healthcare. Its patient-centric approach allows individuals to avoid clinic visits for blood tests and other diagnostic procedures by offering affordable home sample collection and timely access to test results. This model not only minimizes the inconvenience of traditional healthcare services but also significantly reduces wait times for critical health assessments, ultimately making healthcare more seamless and responsive to consumer needs.

OASYS NOW

Seed Round in 2024
OASYS NOW is a technology platform focused on improving the treatment journey for chronic patients by efficiently connecting them with relevant clinical trials tailored to their unique health data. The platform utilizes advanced algorithms to match patients with suitable global clinical trials, thereby increasing their opportunities for personalized treatment options. OASYS NOW emphasizes patient privacy through a privacy-by-design approach while harnessing extensive medical data to enhance health outcomes. Additionally, the company provides secure data-sharing solutions and ethical data processing systems aimed at organizations in the health and genomics sectors, ensuring a robust and secure infrastructure for sensitive health information.

Ladder

Debt Financing in 2024
Ladder is a strength training app that provides a workout plan, every single day. Fitness-seekers can access a complete strength training program on their phone, learn from an expert coach, and engage with a community that shares a passion for fitness. The company is based in Austin, Texas.

Better Health

Series A in 2024
Better Health is a support and supplies platform designed to improve the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The platform offers expert guidance to help patients select and use the appropriate medical supplies while providing education and support to enhance engagement and adherence to treatment. This approach is endorsed by healthcare payers and providers, leading to better health outcomes, reduced overutilization of services, and improved mental health for users. Better Health operates across 48 states and collaborates with major payers, including Medicare, Medicaid, and several private insurers. The platform boasts a high customer satisfaction rating of 98%, reflecting its effectiveness in modernizing the medical supplies industry and lowering healthcare costs for insurers and patients alike.

Fay

Series A in 2024
Fay is a company that connects individuals with dietitians covered by their health insurance, promoting improved dietary habits and overall well-being. It offers consulting services focused on medical nutrition therapy, enabling clients to select a dietitian and arrange either virtual or in-person consultations. Fay designs personalized nutrition plans tailored to each client's needs and works with insurance providers to ensure that these services are accessible and affordable. By facilitating customized nutrition counseling, Fay aims to enhance food-related health outcomes for its clients.

Hona AI

Seed Round in 2024
Hona AI is an AI data platform that collects and maintains healthcare history and records of patients.

Karius

Series C in 2024
Karius, Inc. is a life sciences company based in Redwood City, California, specializing in genomic insights for infectious diseases. The company offers a non-invasive blood test known as the Karius Test, which utilizes sequencing of microbial cell-free DNA to identify and quantify various pathogens, including bacteria, DNA viruses, fungi, and parasites. This test is particularly useful for diagnosing complicated pneumonia, infections in immunocompromised patients, and endocarditis. By mapping the microbial landscape of each patient from a single blood draw, Karius aims to assist clinicians in making rapid and informed treatment decisions. The company's laboratory is CLIA-certified and CAP-accredited, ensuring high standards in clinical laboratory testing. Additionally, Karius provides laboratory services for pathogen biomarker detection tailored to biopharmaceutical companies.

Hippocratic AI

Series A in 2024
Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.

Eleanor Health

Venture Round in 2024
Eleanor Health is a provider of addiction and mental health services focused on delivering long-term recovery outcomes through a value-based care model. Established in 2019 and headquartered in Waltham, Massachusetts, Eleanor Health offers comprehensive, whole-person care for mental health and substance misuse. Its services include evidence-based outpatient care, medication-assisted treatment for addiction, and personalized recovery plans, which are delivered through a network of outpatient clinics, virtually, and in community and home settings. This integrated approach aims to expedite the recovery process for individuals suffering from substance use disorders.

Commure

Venture Round in 2023
Commure, Inc. is an innovative company that has developed an open platform aimed at healthcare software developers. Founded in 2017 and headquartered in San Francisco, California, with additional offices in Boston, Montreal, and Bogota, Commure provides a comprehensive developer platform that facilitates the creation and deployment of next-generation healthcare applications. This platform is built on the open HL7 FHIR standard, offering essential features such as an FHIR API server, security framework, event service bus, EHR integration, and more. By unifying disparate datasets and delivering meaningful insights, Commure enhances performance and fosters collaboration among doctors, nurses, and patients, ultimately empowering the healthcare ecosystem to improve care delivery. The company's commitment to interoperability and innovation positions it as a leader in the healthcare technology space.

Neko Health

Series A in 2023
Neko Health is a Swedish health-tech company focused on enhancing healthcare through prevention and early detection of diseases. It has developed innovative medical scanning technology that enables comprehensive and non-invasive health data collection, making it accessible and affordable for the general public. By leveraging sensor technology and artificial intelligence, Neko Health aims to reduce the prevalence of common diseases and their associated healthcare costs. The company provides doctors and clinicians with tools for flexible and cost-effective examinations, ultimately aiming to improve the quality of healthcare and promote proactive health management.

Zageno

Venture Round in 2023
Zageno Inc. is an online retailer specializing in life science research products, aiming to streamline the purchasing process for researchers globally. Founded in 2015 and headquartered in Cambridge, Massachusetts, Zageno offers a diverse range of over 10 million products, including preparation items, gene editing tools, PCR products, sequencing kits, and various detection and lab accessories. The company features a unique Scientific Score, which provides unbiased, peer-reviewed ratings to assist customers in making informed purchasing decisions. Zageno's platform is designed to enhance convenience and efficiency in acquiring research materials, serving as a reliable sales channel for suppliers and partners in the biotechnology sector. The company also has an office in Berlin, Germany, reflecting its commitment to fostering scientific innovation.

Hippocratic AI

Seed Round in 2023
Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.

Memora Health

Venture Round in 2023
Memora Health Inc., founded in 2016 and based in San Francisco, California, develops an enterprise healthcare productivity platform aimed at automating outpatient communication and enhancing care delivery. The company partners with health systems, health plans, and digital health organizations to streamline clinical workflows, allowing clinicians to focus on their primary responsibilities while proactively engaging patients throughout their care journeys. Memora's platform digitizes high-touch processes, intelligently triaging patient-reported data to the relevant care team members and facilitating proactive, two-way communication between patients and providers. By transforming the way care is delivered, Memora Health seeks to make healthcare more actionable, accessible, and continuous.

CTRL Therapeutics

Seed Round in 2023
CTRL Therapeutics is a biotechnology company based in Toronto, Canada, focused on the development of cell therapies and innovative diagnostic solutions. The company has created a microfluidic platform that enhances the detection of rare circulating tumor cells. This technology is integral to the development of a cancer liquid biopsy test, which aims to predict how patients will respond to targeted therapies. By enabling the evaluation of protein expression on tumor cells, CTRL Therapeutics seeks to provide valuable insights for doctors in tailoring treatment plans for cancer patients.

Paradigm

Series A in 2023
Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.

Breathe Well-being

Series B in 2023
Breathe Well-being is a health technology startup based in India that focuses on managing and preventing type 2 diabetes through a clinically proven program. The company assists individuals with chronic conditions, such as diabetes, in their weight loss efforts by providing personalized one-on-one coaching. Users receive guidance on tracking their weight, meals, and activities, while also learning cognitive behavioral therapy techniques to manage stress. Breathe Well-being promotes long-term healthy habits through individual lifestyle tracking and personalized counseling, complemented by social interactions and community challenges. The program has successfully helped over 10,000 members lose weight, lower blood sugar levels, and reduce the risk of health complications.

Fay

Seed Round in 2023
Fay is a company that connects individuals with dietitians covered by their health insurance, promoting improved dietary habits and overall well-being. It offers consulting services focused on medical nutrition therapy, enabling clients to select a dietitian and arrange either virtual or in-person consultations. Fay designs personalized nutrition plans tailored to each client's needs and works with insurance providers to ensure that these services are accessible and affordable. By facilitating customized nutrition counseling, Fay aims to enhance food-related health outcomes for its clients.

Disclo

Venture Round in 2022
Disclo is a HIPAA compliant platform enabling employers to collect, verify, and manage employee health disclosures and accommodation requests. Disclo helps employees secure the enhancements and protections they need to succeed in their careers without having to disclose their underlying medical condition to their employer.

Fitmint

Seed Round in 2022
Fitmint is a fitness application that incentivizes users to engage in physical activities by rewarding them with cryptocurrency tokens for calories burned. The app tracks various workouts, including walking, running, swimming, cycling, and sports activities, allowing users to compete with friends and monitor their fitness progress. By turning everyday exercise into a rewarding experience, Fitmint aims to motivate individuals to enhance their fitness levels while enjoying a social and competitive environment. The platform effectively transforms routine workouts into engaging challenges, promoting a healthier lifestyle through a unique move-to-earn model.

Examedi

Series A in 2022
Examedi is a healthcare startup that facilitates at-home medical services by connecting patients with independent nurses and lab technicians. Through its telemedicine platform, Examedi allows patients to book diagnostic tests and examinations, including blood tests, pregnancy tests, general checkups, and COVID tests. This service prioritizes accessibility and affordability, ensuring that patients can receive necessary medical care in the comfort of their homes. By coordinating the schedules of healthcare providers with patient needs, Examedi aims to enhance the convenience and efficiency of healthcare delivery.

Orange Health Labs

Series B in 2022
Orange Health Labs is a health tech startup focused on providing diagnostic laboratory services that facilitate remote healthcare delivery. By enabling doctors to conduct tests and diagnostics from a patient's home, the company aims to enhance the accessibility and efficiency of healthcare. Its patient-centric approach allows individuals to avoid clinic visits for blood tests and other diagnostic procedures by offering affordable home sample collection and timely access to test results. This model not only minimizes the inconvenience of traditional healthcare services but also significantly reduces wait times for critical health assessments, ultimately making healthcare more seamless and responsive to consumer needs.

Loop

Series B in 2022
Loop Health is a healthcare provider based in Pune, India, founded in 2018. The company offers a range of services including acute and urgent care, chronic condition management, women's health, health coaching, and preventive care. Loop Health aims to simplify the healthcare experience by connecting patients with family physicians, specialists, and hospitals, facilitating access to major medical treatments. Their team of Loop Coordinators assists patients in finding appropriate doctors, comparing treatment costs, obtaining second opinions, and managing admission procedures, thereby alleviating the stress associated with healthcare decisions. Additionally, Loop Health features a virtual medical practice that supports employees and their families, allowing them to consult with healthcare experts and medical advisors without delay, ultimately promoting better health management and cost-effectiveness.

Eleanor Health

Series C in 2022
Eleanor Health is a provider of addiction and mental health services focused on delivering long-term recovery outcomes through a value-based care model. Established in 2019 and headquartered in Waltham, Massachusetts, Eleanor Health offers comprehensive, whole-person care for mental health and substance misuse. Its services include evidence-based outpatient care, medication-assisted treatment for addiction, and personalized recovery plans, which are delivered through a network of outpatient clinics, virtually, and in community and home settings. This integrated approach aims to expedite the recovery process for individuals suffering from substance use disorders.

Alinea Health

Venture Round in 2022
Alinea Health is a health-tech startup that provides solutions for corporate health. It utilizes large amounts of data and proprietary algorithms to assist the client company's beneficiaries in navigating their health plans, providing personalized and unbiased guidance, recommendations from the most effective doctors in the accredited network, and conveniences such as scheduling consultations and exams. In addition to continuous monitoring, its doctors use the Lifestyle Medicine methodology to promote a healthy lifestyle and lower the risk of developing chronic diseases.

Story Health

Series A in 2022
Story Health Corporation, founded in 2020 and based in Saratoga, California, develops advanced virtualized clinical care software tools aimed at aiding healthcare specialists, particularly neurologists and primary care physicians. The company offers a comprehensive healthcare technology platform that includes virtual patient programs, therapy management, and analytics designed to bridge the gap between clinical evidence and patient experiences. By utilizing data from high-frequency sources, Story Health empowers clinicians to better understand medical situations and make informed decisions regarding the physiological impacts of diseases and therapies. Through its innovative approach, Story Health enhances the ability of specialists to deliver effective patient care.

Ro

Venture Round in 2022
Ro is a telehealth company established in New York City in 2017, specializing in digital health clinics that cater to both men's and women's health, as well as smoking cessation. It offers a patient-centric healthcare system that integrates primary care services, diagnostics, and pharmacy solutions. The platform facilitates direct communication between patients and physicians, providing an end-to-end healthcare experience that encompasses diagnosis, medication delivery, and ongoing care management. Ro's services include personalized treatment options for issues such as erectile dysfunction and smoking cessation, all designed to enhance accessibility and affordability without relying on insurance. The company operates a nationwide provider network, incorporates an in-home care API, and utilizes proprietary pharmacy distribution centers to streamline healthcare services for its users.

Casana

Series B in 2022
Casana is a healthcare technology company based in Rochester, New York, that specializes in in-home cardiac health monitoring solutions. Its flagship product, the Heart Seat, is a cloud-connected toilet seat designed to allow patients to effortlessly monitor critical health metrics such as heart rate, blood pressure, blood oxygenation, and cardiac output from the comfort of their homes. The Heart Seat integrates three key sensors: a single-lead ECG for measuring the heart's electrical activity, PPG sensors that assess blood volume, and BCG sensors that track the mechanical activity of the heart. This innovative device aims to assist medical teams in managing chronic conditions by providing continuous, reliable health data outside traditional healthcare settings. Casana's technology is focused on fostering proactive health management and improving patient outcomes.

The Breakaway

Seed Round in 2022
The Breakaway is a developer of a motivational coaching app specifically designed for fitness enthusiasts, with a primary focus on cyclists. The application offers users intelligent goal-setting and personalized insights to facilitate faster progress in their fitness journeys. Additionally, it provides motivational feedback and tips from professional athletes, ensuring that users remain engaged and informed as they work towards achieving their goals.

Well

Series B in 2021
Well Dot, Inc. is a health technology company that has developed an artificial intelligence-based consumer health engagement platform and mobile application. Founded in 2019 and headquartered in Chapel Hill, North Carolina, with additional offices in Massachusetts, New York, and Minnesota, Well's platform uses clinical and consumer data to offer personalized health guidance and support. It analyzes individual health triggers to promote tailored, achievable steps for members to improve their health. The platform is designed to engage, educate, and empower users, providing easy-to-understand explanations and active assistance from health teams. By focusing on creating a meaningful and personalized health journey, Well aims to motivate individuals to adopt healthier habits and achieve better health outcomes.

Cadence Solutions

Series B in 2021
Cadence is a pioneering health technology company helping the nation’s largest health systems deliver world-class care outside of the four walls of the hospital.

Ophelia

Series B in 2021
Ophelia Health, established in 2019 and headquartered in New York, specializes in medication-assisted treatment for opioid dependency. The company facilitates telemedicine consultations between patients and doctors, and provides necessary medications. Ophelia Health differentiates itself by combining medical expertise with a client-centered approach, prioritizing privacy and empowering individuals to make their own treatment decisions.

Sword Health

Series D in 2021
Sword Health is a digital health company specializing in physical rehabilitation. It employs artificial intelligence to deliver personalized care to patients worldwide, anytime, anywhere. The platform offers interactive exercise routines supervised by remote physiotherapists, aiming to reduce costs and improve accessibility to physical therapy. Clinicians can utilize the data collected to enhance decision-making processes.

Shyft

Seed Round in 2021
Shyft is a personalized wellness platform that offers guided nutrition, meditation, and yoga classes. Shyft offers a variety of Yoga based interactive classes and DIY content focused on managing specific conditions across women's health, chronic ailments, everyday wellness, and mental health.

Zageno

Series C in 2021
Zageno Inc. is an online retailer specializing in life science research products, aiming to streamline the purchasing process for researchers globally. Founded in 2015 and headquartered in Cambridge, Massachusetts, Zageno offers a diverse range of over 10 million products, including preparation items, gene editing tools, PCR products, sequencing kits, and various detection and lab accessories. The company features a unique Scientific Score, which provides unbiased, peer-reviewed ratings to assist customers in making informed purchasing decisions. Zageno's platform is designed to enhance convenience and efficiency in acquiring research materials, serving as a reliable sales channel for suppliers and partners in the biotechnology sector. The company also has an office in Berlin, Germany, reflecting its commitment to fostering scientific innovation.

Beacon Biosignals

Series A in 2021
Beacon Biosignals is a company focused on enhancing human health through the application of artificial intelligence in the analysis of brain activity. It has developed a platform that provides rapid and accurate electroencephalogram (EEG) reports, streamlining the diagnostic process by eliminating the need for adjudication and utilizing improved criteria for inclusion and exclusion. The platform captures real-time brain activity, supporting healthcare professionals in the study of neurological and psychiatric disorders. By enabling more precise quantification of treatment plans and helping identify optimal patient populations, Beacon Biosignals aims to facilitate targeted interventions and advance the field of brain analytics.

Better Health

Series A in 2021
Better Health is a support and supplies platform designed to improve the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The platform offers expert guidance to help patients select and use the appropriate medical supplies while providing education and support to enhance engagement and adherence to treatment. This approach is endorsed by healthcare payers and providers, leading to better health outcomes, reduced overutilization of services, and improved mental health for users. Better Health operates across 48 states and collaborates with major payers, including Medicare, Medicaid, and several private insurers. The platform boasts a high customer satisfaction rating of 98%, reflecting its effectiveness in modernizing the medical supplies industry and lowering healthcare costs for insurers and patients alike.

Sprinter Health

Series A in 2021
Sprinter Health is a mobile health company that specializes in providing on-demand healthcare services directly to patients' homes. By sending full-time nurses and phlebotomists, known as "Sprinters," the company aims to improve access to preventive care and enhance the overall patient experience. Sprinter Health employs a cost-effective, hybrid care model that facilitates connections between patients and necessary healthcare services, ultimately striving to improve health outcomes and patient satisfaction. This approach allows patients to receive quality medical care in the comfort of their own homes, ensuring convenience and accessibility without compromising on care quality.

Loop

Series A in 2021
Loop Health is a healthcare provider based in Pune, India, founded in 2018. The company offers a range of services including acute and urgent care, chronic condition management, women's health, health coaching, and preventive care. Loop Health aims to simplify the healthcare experience by connecting patients with family physicians, specialists, and hospitals, facilitating access to major medical treatments. Their team of Loop Coordinators assists patients in finding appropriate doctors, comparing treatment costs, obtaining second opinions, and managing admission procedures, thereby alleviating the stress associated with healthcare decisions. Additionally, Loop Health features a virtual medical practice that supports employees and their families, allowing them to consult with healthcare experts and medical advisors without delay, ultimately promoting better health management and cost-effectiveness.

Orange Health Labs

Series A in 2021
Orange Health Labs is a health tech startup focused on providing diagnostic laboratory services that facilitate remote healthcare delivery. By enabling doctors to conduct tests and diagnostics from a patient's home, the company aims to enhance the accessibility and efficiency of healthcare. Its patient-centric approach allows individuals to avoid clinic visits for blood tests and other diagnostic procedures by offering affordable home sample collection and timely access to test results. This model not only minimizes the inconvenience of traditional healthcare services but also significantly reduces wait times for critical health assessments, ultimately making healthcare more seamless and responsive to consumer needs.

Breathe Well-being

Series A in 2021
Breathe Well-being is a health technology startup based in India that focuses on managing and preventing type 2 diabetes through a clinically proven program. The company assists individuals with chronic conditions, such as diabetes, in their weight loss efforts by providing personalized one-on-one coaching. Users receive guidance on tracking their weight, meals, and activities, while also learning cognitive behavioral therapy techniques to manage stress. Breathe Well-being promotes long-term healthy habits through individual lifestyle tracking and personalized counseling, complemented by social interactions and community challenges. The program has successfully helped over 10,000 members lose weight, lower blood sugar levels, and reduce the risk of health complications.

Athelas

Series B in 2021
Athelas, Inc. is a healthcare company based in Mountain View, California, that specializes in developing and manufacturing in-home blood analysis devices aimed at diagnosing infections, inflammations, and malignancies. Founded in 2002, Athelas has created a portable optical unit that analyzes blood samples from a single drop, providing diagnostic reports to monitor the immune system. The company's FDA-cleared device is designed to help chronically ill patients manage their health at home, offering additional monitoring for blood pressure, weight, glucose levels, and medication adherence. This technology enables patients to monitor their immunity and assists healthcare providers in the early detection of conditions such as leukemia and other inflammatory diseases. Athelas operates as a subsidiary of MerLion Pharmaceuticals Pte. Ltd.

Cadence Solutions

Series A in 2021
Cadence is a pioneering health technology company helping the nation’s largest health systems deliver world-class care outside of the four walls of the hospital.

OM1

Series D in 2021
OM1, Inc. is a digital health company that specializes in developing a platform for healthcare organizations to measure and forecast patient outcomes. The platform is designed to assist hospitals, health systems, and other healthcare providers in meeting various patient reported and clinical outcomes requirements for value-based care programs. By leveraging advanced predictive and prescriptive analytics, OM1 aims to mitigate risks, lower costs, and enhance the understanding of treatment outcomes across the care continuum. The company's technology gathers and synthesizes clinical data to provide AI-driven insights, enabling healthcare organizations to analyze and utilize outcomes data effectively. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.

Osana

Series A in 2021
Osana is a healthtech company that provides a patient-centric omnichannel platform designed to improve the efficiency of healthcare resources. The platform offers subscription-based primary care services, which include features such as patient portals and data analysis. Through these capabilities, Osana delivers a range of services, including clinical analysis, emergency ambulance services, and video consultations. This approach enables healthcare providers to enhance their operations and deliver superior experiences to their patients.

Sword Health

Series C in 2021
Sword Health is a digital health company specializing in physical rehabilitation. It employs artificial intelligence to deliver personalized care to patients worldwide, anytime, anywhere. The platform offers interactive exercise routines supervised by remote physiotherapists, aiming to reduce costs and improve accessibility to physical therapy. Clinicians can utilize the data collected to enhance decision-making processes.

Terra API

Seed Round in 2021
Terra API specializes in facilitating the seamless transfer of health data between various applications and devices. The company provides an online application programming interface (API) that enables developers to connect easily with health apps, wearables, sensors, and blood laboratories. By utilizing standard protocols for data exchange, Terra API allows applications to accept requests and return responses in commonly used formats, supporting efficient communication across diverse fitness tracking devices. This integration empowers users to share and access their health and fitness data from multiple sources, enhancing the overall user experience in health management.

Ophelia

Series A in 2021
Ophelia Health, established in 2019 and headquartered in New York, specializes in medication-assisted treatment for opioid dependency. The company facilitates telemedicine consultations between patients and doctors, and provides necessary medications. Ophelia Health differentiates itself by combining medical expertise with a client-centered approach, prioritizing privacy and empowering individuals to make their own treatment decisions.

Hallow

Series A in 2021
Hallow is a Catholic prayer and meditation app that hopes to help folks grow closer to God. It helps in finding peace, deepen the relationship with God, and sleeping soundly every night. It was founded in 2018 and is based in Chicago, Illinois.

Tempo

Series C in 2021
Tempo designs and develops a home fitness platform with personal guidance to help users in their training sessions. It features live elite trainers who can help users when they make mistakes. It has built-in three-dimensional sensors that track form, counts reps, and recommend weights. It helps users to improve in real-time. Powered by 3D motion sensors and AI, it analyzes 25 of the body’s essential joints as users work out and gives understood form feedback. Moawia Eldeeb and Joshua Augustin founded it as Pivot in 2015, with its headquarters in San Francisco in California.

Cityblock

Series C in 2021
Cityblock Health, established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a communication and task management tool called Commons. Cityblock's model focuses on prevention-oriented care and collaboration with community-based organizations to deliver personalized care to low-income urban residents. During the COVID-19 pandemic, the company developed a risk assessment model to identify high-risk members within its network.

Ro

Series D in 2021
Ro is a telehealth company established in New York City in 2017, specializing in digital health clinics that cater to both men's and women's health, as well as smoking cessation. It offers a patient-centric healthcare system that integrates primary care services, diagnostics, and pharmacy solutions. The platform facilitates direct communication between patients and physicians, providing an end-to-end healthcare experience that encompasses diagnosis, medication delivery, and ongoing care management. Ro's services include personalized treatment options for issues such as erectile dysfunction and smoking cessation, all designed to enhance accessibility and affordability without relying on insurance. The company operates a nationwide provider network, incorporates an in-home care API, and utilizes proprietary pharmacy distribution centers to streamline healthcare services for its users.

Ossium Health

Series B in 2021
Ossium Health, Inc. is engaged in the development and manufacturing of cell therapy products aimed at treating leukemia, other blood cancers, and tissue damage, as well as addressing radiation poisoning. The company offers a range of innovative therapies, including HPC, Marrow, which features HLA-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients; Chimera, which enhances organ transplantation; and Chymalis, composed of mesenchymal stem cells that promote the healing of damaged bone and muscle tissue. Additionally, Ossium provides bone marrow cells for research purposes in oncology and immunology. Founded in 2016 and headquartered in San Francisco, California, Ossium Health focuses on improving health outcomes and longevity through advanced bioengineering techniques.

Sprinter Health

Seed Round in 2021
Sprinter Health is a mobile health company that specializes in providing on-demand healthcare services directly to patients' homes. By sending full-time nurses and phlebotomists, known as "Sprinters," the company aims to improve access to preventive care and enhance the overall patient experience. Sprinter Health employs a cost-effective, hybrid care model that facilitates connections between patients and necessary healthcare services, ultimately striving to improve health outcomes and patient satisfaction. This approach allows patients to receive quality medical care in the comfort of their own homes, ensuring convenience and accessibility without compromising on care quality.

Truvian Sciences

Series C in 2021
Truvian Sciences Inc, based in San Diego, California, specializes in developing automated diagnostic equipment that transforms the blood testing industry. Founded in 2015, the company offers a benchtop system designed to deliver lab-accurate results for a range of health tests. Its comprehensive wellness panel includes commonly ordered routine blood tests such as complete blood count, metabolic panel, and lipid panel, all processed from a single sample. Additionally, Truvian Sciences provides a software platform that enables healthcare practitioners to efficiently share test data with patients.

Casana

Series A in 2021
Casana is a healthcare technology company based in Rochester, New York, that specializes in in-home cardiac health monitoring solutions. Its flagship product, the Heart Seat, is a cloud-connected toilet seat designed to allow patients to effortlessly monitor critical health metrics such as heart rate, blood pressure, blood oxygenation, and cardiac output from the comfort of their homes. The Heart Seat integrates three key sensors: a single-lead ECG for measuring the heart's electrical activity, PPG sensors that assess blood volume, and BCG sensors that track the mechanical activity of the heart. This innovative device aims to assist medical teams in managing chronic conditions by providing continuous, reliable health data outside traditional healthcare settings. Casana's technology is focused on fostering proactive health management and improving patient outcomes.

Elephant Healthcare

Series A in 2021
Elephant Healthcare Limited, founded in 2018 and based in London, develops a digital health system aimed at revolutionizing global healthcare. The company constructs a global digital health network that links various components of the healthcare ecosystem. Founded by medical professionals, Elephant leverages technological innovations to tackle significant challenges in healthcare, focusing on cost reduction and improving patient outcomes. Its software platform digitizes medical clinics, fostering connectivity and providing tools to enhance primary care. Additionally, the platform utilizes blockchain and decentralized infrastructure to integrate existing services and facilitate the development of new health applications, particularly benefiting hospitals serving low-income populations.

Curai Health

Series B in 2020
Curai Health is a virtual care company founded in 2017 by Neal Khosla and Xavier Amatriain, headquartered in Palo Alto. The company leverages artificial intelligence to provide chat-based primary care services, aiming to make high-quality and affordable healthcare accessible to everyone, anytime. Curai Health's platform integrates clinicians with advanced AI and machine learning tools to create a learning healthcare system that enhances the efficiency and cost-effectiveness of medical care. By facilitating better communication between patients and healthcare professionals, the platform aids in accurate diagnosis and treatment. Curai Health offers its services directly to consumers and through partnerships with enterprises.

Well

Series A in 2020
Well Dot, Inc. is a health technology company that has developed an artificial intelligence-based consumer health engagement platform and mobile application. Founded in 2019 and headquartered in Chapel Hill, North Carolina, with additional offices in Massachusetts, New York, and Minnesota, Well's platform uses clinical and consumer data to offer personalized health guidance and support. It analyzes individual health triggers to promote tailored, achievable steps for members to improve their health. The platform is designed to engage, educate, and empower users, providing easy-to-understand explanations and active assistance from health teams. By focusing on creating a meaningful and personalized health journey, Well aims to motivate individuals to adopt healthier habits and achieve better health outcomes.

Cityblock

Series C in 2020
Cityblock Health, established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a communication and task management tool called Commons. Cityblock's model focuses on prevention-oriented care and collaboration with community-based organizations to deliver personalized care to low-income urban residents. During the COVID-19 pandemic, the company developed a risk assessment model to identify high-risk members within its network.

Story Health

Seed Round in 2020
Story Health Corporation, founded in 2020 and based in Saratoga, California, develops advanced virtualized clinical care software tools aimed at aiding healthcare specialists, particularly neurologists and primary care physicians. The company offers a comprehensive healthcare technology platform that includes virtual patient programs, therapy management, and analytics designed to bridge the gap between clinical evidence and patient experiences. By utilizing data from high-frequency sources, Story Health empowers clinicians to better understand medical situations and make informed decisions regarding the physiological impacts of diseases and therapies. Through its innovative approach, Story Health enhances the ability of specialists to deliver effective patient care.

Tempo

Series B in 2020
Tempo designs and develops a home fitness platform with personal guidance to help users in their training sessions. It features live elite trainers who can help users when they make mistakes. It has built-in three-dimensional sensors that track form, counts reps, and recommend weights. It helps users to improve in real-time. Powered by 3D motion sensors and AI, it analyzes 25 of the body’s essential joints as users work out and gives understood form feedback. Moawia Eldeeb and Joshua Augustin founded it as Pivot in 2015, with its headquarters in San Francisco in California.

Ro

Series C in 2020
Ro is a telehealth company established in New York City in 2017, specializing in digital health clinics that cater to both men's and women's health, as well as smoking cessation. It offers a patient-centric healthcare system that integrates primary care services, diagnostics, and pharmacy solutions. The platform facilitates direct communication between patients and physicians, providing an end-to-end healthcare experience that encompasses diagnosis, medication delivery, and ongoing care management. Ro's services include personalized treatment options for issues such as erectile dysfunction and smoking cessation, all designed to enhance accessibility and affordability without relying on insurance. The company operates a nationwide provider network, incorporates an in-home care API, and utilizes proprietary pharmacy distribution centers to streamline healthcare services for its users.

Ophelia

Seed Round in 2020
Ophelia Health, established in 2019 and headquartered in New York, specializes in medication-assisted treatment for opioid dependency. The company facilitates telemedicine consultations between patients and doctors, and provides necessary medications. Ophelia Health differentiates itself by combining medical expertise with a client-centered approach, prioritizing privacy and empowering individuals to make their own treatment decisions.

Karius

Series B in 2020
Karius, Inc. is a life sciences company based in Redwood City, California, specializing in genomic insights for infectious diseases. The company offers a non-invasive blood test known as the Karius Test, which utilizes sequencing of microbial cell-free DNA to identify and quantify various pathogens, including bacteria, DNA viruses, fungi, and parasites. This test is particularly useful for diagnosing complicated pneumonia, infections in immunocompromised patients, and endocarditis. By mapping the microbial landscape of each patient from a single blood draw, Karius aims to assist clinicians in making rapid and informed treatment decisions. The company's laboratory is CLIA-certified and CAP-accredited, ensuring high standards in clinical laboratory testing. Additionally, Karius provides laboratory services for pathogen biomarker detection tailored to biopharmaceutical companies.

OM1

Series C in 2019
OM1, Inc. is a digital health company that specializes in developing a platform for healthcare organizations to measure and forecast patient outcomes. The platform is designed to assist hospitals, health systems, and other healthcare providers in meeting various patient reported and clinical outcomes requirements for value-based care programs. By leveraging advanced predictive and prescriptive analytics, OM1 aims to mitigate risks, lower costs, and enhance the understanding of treatment outcomes across the care continuum. The company's technology gathers and synthesizes clinical data to provide AI-driven insights, enabling healthcare organizations to analyze and utilize outcomes data effectively. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.

Well

Seed Round in 2019
Well Dot, Inc. is a health technology company that has developed an artificial intelligence-based consumer health engagement platform and mobile application. Founded in 2019 and headquartered in Chapel Hill, North Carolina, with additional offices in Massachusetts, New York, and Minnesota, Well's platform uses clinical and consumer data to offer personalized health guidance and support. It analyzes individual health triggers to promote tailored, achievable steps for members to improve their health. The platform is designed to engage, educate, and empower users, providing easy-to-understand explanations and active assistance from health teams. By focusing on creating a meaningful and personalized health journey, Well aims to motivate individuals to adopt healthier habits and achieve better health outcomes.

Zageno

Series B in 2019
Zageno Inc. is an online retailer specializing in life science research products, aiming to streamline the purchasing process for researchers globally. Founded in 2015 and headquartered in Cambridge, Massachusetts, Zageno offers a diverse range of over 10 million products, including preparation items, gene editing tools, PCR products, sequencing kits, and various detection and lab accessories. The company features a unique Scientific Score, which provides unbiased, peer-reviewed ratings to assist customers in making informed purchasing decisions. Zageno's platform is designed to enhance convenience and efficiency in acquiring research materials, serving as a reliable sales channel for suppliers and partners in the biotechnology sector. The company also has an office in Berlin, Germany, reflecting its commitment to fostering scientific innovation.

Curai Health

Series A in 2018
Curai Health is a virtual care company founded in 2017 by Neal Khosla and Xavier Amatriain, headquartered in Palo Alto. The company leverages artificial intelligence to provide chat-based primary care services, aiming to make high-quality and affordable healthcare accessible to everyone, anytime. Curai Health's platform integrates clinicians with advanced AI and machine learning tools to create a learning healthcare system that enhances the efficiency and cost-effectiveness of medical care. By facilitating better communication between patients and healthcare professionals, the platform aids in accurate diagnosis and treatment. Curai Health offers its services directly to consumers and through partnerships with enterprises.

OM1

Series B in 2018
OM1, Inc. is a digital health company that specializes in developing a platform for healthcare organizations to measure and forecast patient outcomes. The platform is designed to assist hospitals, health systems, and other healthcare providers in meeting various patient reported and clinical outcomes requirements for value-based care programs. By leveraging advanced predictive and prescriptive analytics, OM1 aims to mitigate risks, lower costs, and enhance the understanding of treatment outcomes across the care continuum. The company's technology gathers and synthesizes clinical data to provide AI-driven insights, enabling healthcare organizations to analyze and utilize outcomes data effectively. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.

Ro

Seed Round in 2017
Ro is a telehealth company established in New York City in 2017, specializing in digital health clinics that cater to both men's and women's health, as well as smoking cessation. It offers a patient-centric healthcare system that integrates primary care services, diagnostics, and pharmacy solutions. The platform facilitates direct communication between patients and physicians, providing an end-to-end healthcare experience that encompasses diagnosis, medication delivery, and ongoing care management. Ro's services include personalized treatment options for issues such as erectile dysfunction and smoking cessation, all designed to enhance accessibility and affordability without relying on insurance. The company operates a nationwide provider network, incorporates an in-home care API, and utilizes proprietary pharmacy distribution centers to streamline healthcare services for its users.

Commure

Seed Round in 2017
Commure, Inc. is an innovative company that has developed an open platform aimed at healthcare software developers. Founded in 2017 and headquartered in San Francisco, California, with additional offices in Boston, Montreal, and Bogota, Commure provides a comprehensive developer platform that facilitates the creation and deployment of next-generation healthcare applications. This platform is built on the open HL7 FHIR standard, offering essential features such as an FHIR API server, security framework, event service bus, EHR integration, and more. By unifying disparate datasets and delivering meaningful insights, Commure enhances performance and fosters collaboration among doctors, nurses, and patients, ultimately empowering the healthcare ecosystem to improve care delivery. The company's commitment to interoperability and innovation positions it as a leader in the healthcare technology space.

OM1

Series A in 2017
OM1, Inc. is a digital health company that specializes in developing a platform for healthcare organizations to measure and forecast patient outcomes. The platform is designed to assist hospitals, health systems, and other healthcare providers in meeting various patient reported and clinical outcomes requirements for value-based care programs. By leveraging advanced predictive and prescriptive analytics, OM1 aims to mitigate risks, lower costs, and enhance the understanding of treatment outcomes across the care continuum. The company's technology gathers and synthesizes clinical data to provide AI-driven insights, enabling healthcare organizations to analyze and utilize outcomes data effectively. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.

TearScience

Series D in 2016
TearScience, Inc. is a medical device company based in Morrisville, North Carolina, focused on the identification, diagnosis, and treatment of Meibomian Gland Dysfunction (MGD), which is the primary cause of evaporative dry eye affecting over 100 million people globally. The company has developed innovative devices such as the LipiFlow Activator, which delivers automated therapeutic energies to meibomian glands while safeguarding the eye's delicate structures, and LipiScan, an imaging system that allows eye care professionals to assess gland health. MGD is often under-recognized and contributes significantly to dry eye symptoms such as irritation, dryness, and visual disturbances. By providing a comprehensive in-office system, TearScience enables eye care professionals to effectively address the root causes of evaporative dry eye, ultimately improving patient outcomes. The company, originally known as Kolis Scientific, Inc., was rebranded in 2005 and is now a subsidiary of Johnson & Johnson Surgical Vision, Inc.

SynapDx

Series B in 2012
SynapDx is a laboratory testing service provider focused on the early detection of autism spectrum disorders (ASDs) in children. Founded by Stanley Lapidus, the company aims to assist physicians in evaluating developmental disorders through innovative blood-based diagnostic tests and equipment. By collaborating with experts in ASD and gene expression from prominent institutions, SynapDx seeks to enhance the capability of healthcare providers to identify early symptoms of autism. The company is headquartered in Lexington, Massachusetts, and has secured funding from notable investors, including North Bridge Venture Partners, Bain Capital Ventures, and General Catalyst Partners.

OvaScience

Series B in 2012
OvaScience, Inc. was a fertility company focused on developing innovative treatments for women facing infertility challenges. The company was founded in 2011 and was headquartered in Waltham, Massachusetts. OvaScience specialized in proprietary technology derived from the discovery of egg precursor (EggPC) cells, which allowed for the enhancement of egg quality and improved outcomes in in vitro fertilization (IVF). Their treatment options included OvaPrime, which aimed to restore a woman's egg production using her own EggPC cells, OvaTure, designed to mature these cells into fertilizable eggs outside the body, and AUGMENT, which utilized mitochondria from EggPC cells to enhance fertilization and pregnancy rates. The company also explored OvaXon for preventing inherited diseases. OvaScience was co-founded by a team of experts from Harvard Medical School and was backed by prominent life science investors. In December 2018, OvaScience was acquired by Millendo Therapeutics in a reverse merger.

Lose It!

Series A in 2012
Lose It! is a weight loss application that aims to help individuals achieve and maintain a healthy weight through personalized tracking and community support. The platform allows users to set specific weight loss goals, track their daily food intake and exercise, and access a global community for continuous encouragement. Each member receives a customized plan and daily calorie budget based on their personal information and health objectives. Lose It! employs user-friendly tracking tools and a comprehensive database of food and exercise options, empowering users to manage their weight effectively. The application is grounded in nutritional science and behavioral data, promoting healthier living and fostering a supportive environment for its members.

SynapDx

Series A in 2010
SynapDx is a laboratory testing service provider focused on the early detection of autism spectrum disorders (ASDs) in children. Founded by Stanley Lapidus, the company aims to assist physicians in evaluating developmental disorders through innovative blood-based diagnostic tests and equipment. By collaborating with experts in ASD and gene expression from prominent institutions, SynapDx seeks to enhance the capability of healthcare providers to identify early symptoms of autism. The company is headquartered in Lexington, Massachusetts, and has secured funding from notable investors, including North Bridge Venture Partners, Bain Capital Ventures, and General Catalyst Partners.

TearScience

Series C in 2010
TearScience, Inc. is a medical device company based in Morrisville, North Carolina, focused on the identification, diagnosis, and treatment of Meibomian Gland Dysfunction (MGD), which is the primary cause of evaporative dry eye affecting over 100 million people globally. The company has developed innovative devices such as the LipiFlow Activator, which delivers automated therapeutic energies to meibomian glands while safeguarding the eye's delicate structures, and LipiScan, an imaging system that allows eye care professionals to assess gland health. MGD is often under-recognized and contributes significantly to dry eye symptoms such as irritation, dryness, and visual disturbances. By providing a comprehensive in-office system, TearScience enables eye care professionals to effectively address the root causes of evaporative dry eye, ultimately improving patient outcomes. The company, originally known as Kolis Scientific, Inc., was rebranded in 2005 and is now a subsidiary of Johnson & Johnson Surgical Vision, Inc.

Lose It!

Seed Round in 2010
Lose It! is a weight loss application that aims to help individuals achieve and maintain a healthy weight through personalized tracking and community support. The platform allows users to set specific weight loss goals, track their daily food intake and exercise, and access a global community for continuous encouragement. Each member receives a customized plan and daily calorie budget based on their personal information and health objectives. Lose It! employs user-friendly tracking tools and a comprehensive database of food and exercise options, empowering users to manage their weight effectively. The application is grounded in nutritional science and behavioral data, promoting healthier living and fostering a supportive environment for its members.

Sprinter Health

Sprinter Health is a mobile health company that specializes in providing on-demand healthcare services directly to patients' homes. By sending full-time nurses and phlebotomists, known as "Sprinters," the company aims to improve access to preventive care and enhance the overall patient experience. Sprinter Health employs a cost-effective, hybrid care model that facilitates connections between patients and necessary healthcare services, ultimately striving to improve health outcomes and patient satisfaction. This approach allows patients to receive quality medical care in the comfort of their own homes, ensuring convenience and accessibility without compromising on care quality.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.